A new wave of interest in cell-free protein synthesis (CFPS) systems has shown their utility
for producing proteins at high titers, establishing genetic regulatory element libraries (eg …

Vibrio natriegens constitutes one of the fastest-growing nonpathogenic bacteria and a
potential novel workhorse for many biotechnological applications. Here, we report the …

The fast growing bacterium Vibrio natriegens is an emerging microbial host for
biotechnology. Harnessing its productive cellular components may offer a compelling …

Over the last 50 years, Cell-Free Protein Synthesis (CFPS) has emerged as a powerful
technology to harness the transcriptional and translational capacity of cells within a test tube …

Crude extract based cell-free protein synthesis (CFPS) has emerged as a powerful
technology platform for high-throughput protein production and genetic part characterization …

Cell-free protein synthesis (CFPS) is a technology for the production of proteins in vitro,
which has emerged as a robust platform for biotechnology and synthetic biology …

In recent years, cell-free protein synthesis (CFPS) systems have been used to synthesize
proteins, prototype genetic elements, manufacture chemicals, and diagnose diseases …

Cell-free protein synthesis (CFPS) systems enable the production of protein without the use
of living, intact cells. An emerging area of interest is to use CFPS systems to characterize …

Cell-free protein synthesis (CFPS) is a platform technology that provides new opportunities
for protein expression, metabolic engineering, therapeutic development, education, and …

Escherichia coli cell‐free protein synthesis (CFPS) uses E. coli extracts to make active
proteins in vitro. The basic CFPS reaction mixture is comprised of four main reagent …